Benzinga | Nov 11, 2021 10:59AM EST

A Preview Of Meridian Bioscience's Earnings

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.

Analysts estimate that Meridian Bioscience will likely report an Earnings Per Share (EPS) of $0.20

Meridian Bioscience bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed on EPS by -29.03%, which was followed by a 0.0% drop in the share price the next day.

Here's a look at Meridian Bioscience's past performance and the resulting price change:

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020EPS Estimate 0.31 0.48 0.42 0.14EPS Actual 0.22 0.56 0.65 0.19Price Change % -3.28% 6.68% 22.86% 4.64%

Stock Performance

Shares of Meridian Bioscience were trading at $18.77 as of November 10. Over the last 52-week period, shares are up 12.03%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here